Gemphire Therapeutics Inc. Common Stock


Updates from The Motley Fool

Latest updates on Gemphire Therapeutics Inc. Common Stock from Fool.com.

There is no available coverage of Gemphire Therapeutics Inc. Common Stock at this time.



Stock Performance

GEMP vs. S&P 500 | 2 Year Performance
View Interactive GEMP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Gemphire Therapeutics Inc. Common Stock.
Current Price: $10.91
Prev Close: $11.61
Open: $11.46
Bid: $0.00
Ask: $16.75
Day's Range: $10.77 - $11.46
52wk Range: $8.50 - $13.98
Volume: 7,375
Avg Vol 55,931
Market Cap: $101.14M
P/E (ttm): 10.65
EPS (ttm): $1.09
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Gemphire Therapeutics Inc. Common Stock.
CAPS Rating 0 out of 5
 
1 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think Gemphire Therapeutics Inc. Common Stock will perform against the market?



You pick for Gemphire Therapeutics Inc. Common Stock is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Gemphire Therapeutics Inc. Common Stock.

Gemphire Therapeutics Inc. Common Stock

  • Exchange: NASDAQ